Research in Motion: Anita Clayton, MD

May 1, 2024 by

I’ve helped develop treatments for major depressive disorder, primarily monoamine reuptake inhibitors, but most recently for postpartum depression with novel mechanisms of action, including allopregnanolone analogs, and psychedelics, specifically psilocybin and kappa opioid receptor antagonists. —Anita Clayton, MD, Professor and Chair, Department of Psychiatry and Neurobehavioral Sciences

To watch more Research in Motion videos in this series:


Filed Under: Research